Exhibit 107

 

Calculation of Filing Fee Tables

 

Form S-1

 

(Form Type)

 

Sonnet BioTherapeutics Holdings, Inc.

 

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered and Carry Forward Securities

 

   Security Type  Security
Class Title
  Fee
Calculation
or Carry
Forward
Rule
   Amount
Registered
   Proposed
Maximum
Offering
Price Per
Share
   Maximum
Aggregate
Offering
Price(1)
   Fee Rate   Amount of
Registration
Fee
 

Fees to Be

Paid

  Equity  Common Stock, $0.0001 par value per share(2)(3)   457(o)                    $ 17,250,000     0.0001102     1,900.95  

Fees to Be

Paid

  Equity  Pre-Funded Warrants(3)   457(g)                       (4)

Fees to Be

Paid

  Equity  Common Warrants(3)   457(g)                       (4)

Fees to Be

Paid

  Equity  Underwriter Warrants   457(g)                       (4)

Fees to Be

Paid

  Equity  Common Stock underlying Pre-Funded Warrants(2)(3)   457(o)             

(3

)   

0.0001102

    (3)

Fees to Be

Paid

 

Equity

  Common Stock underlying Common Warrants(2)   457(o)            $

34,500,000

    

0.0001102

    

3,801.90

 

Fees to Be

Paid

  Equity  Common Stock underlying Underwriter Warrants(2)   457(o)            $

1,509,375

    

0.0001102

    

166.34

     Total Fees Previously Paid                         
     Total Fee Offsets                       $ 
     Net Fee Due                       $ 5,869.19 (5)

 

(1) Estimated solely for the purpose of calculating the amount of the registration fee in pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the “Securities Act”).
   
(2 Pursuant to Rule 416(a) under the Securities Act, this registration statement shall also cover an indeterminate number of shares that may be issued and resold resulting from stock splits, stock dividends or similar transactions.
   
(3) The proposed maximum aggregate offering price of the common stock will be reduced on a dollar-for-dollar basis based on the offering price of any pre-funded warrants issued in the offering, and the proposed maximum aggregate offering price of the pre-funded warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any common stock issued in the offering. Accordingly, the proposed maximum aggregate offering price of the common stock, pre-funded warrants and accompanying common warrants (including the common stock issuable upon exercise of the pre-funded warrants), if any, is $13,800,000 (including the underwriters’ option to purchase additional shares of common stock).
   
(4) No separate registration fee is payable pursuant to Rule 457(g) under the Securities Act.
   
(5) $3,450.64 of the fee has previously been paid.